Quaternary Ammonium Compounds
Ethyl Methanesulfonate
Diphenylhexatriene
Sulfhydryl Reagents
Cetrimonium Compounds
Indicators and Reagents
Cations
Surface-Active Agents
Parasympathomimetics
Structure-Activity Relationship
Liposomes
Mutagenesis, Site-Directed
Amino Acid Substitution
Xenopus laevis
Ion Channel Gating
Protein Conformation
Protein Structure, Tertiary
Acetylcholine
Bodily Secretions
Oocytes
Xenopus
Binding Sites
Biological Transport
Membrane Potentials
Protein Binding
Cell Membrane
Molecular Sequence Data
Sodium
Mutation
Patch-Clamp Techniques
Amino Acid Sequence
Molecular Structure
Sulfur Compounds
Volatile Organic Compounds
Plant Extracts
Drug Evaluation, Preclinical
Magnetic Resonance Spectroscopy
Heterocyclic Compounds
Inhibitory Concentration 50
Small Molecule Libraries
Organotin Compounds
Spiro Compounds
Chromatography, High Pressure Liquid
Stereoisomerism
Drug Design
Dose-Response Relationship, Drug
Organometallic Compounds
Organoselenium Compounds
Drug Screening Assays, Antitumor
Organophosphorus Compounds
Gas Chromatography-Mass Spectrometry
Epoxy Compounds
Gastroenteritis
High-Throughput Screening Assays
p-Methoxy-N-methylphenethylamine
Hydrocarbons, Aromatic
Enzyme Inhibitors
Mass Spectrometry
Organic Chemicals
Terphenyl Compounds
Furans
Oxidation-Reduction
Spectrophotometry, Ultraviolet
Glycosides
Heterocyclic Compounds, 2-Ring
Spectrophotometry, Infrared
Plants, Medicinal
Quantitative Structure-Activity Relationship
Biotransformation
Biodegradation, Environmental
Chromatography, Thin Layer
Microbial Sensitivity Tests
Biological Products
Cell Survival
Chemistry
Pharmaceutical Preparations
Combinatorial Chemistry Techniques
Hydrogen-Ion Concentration
Bacteria
Antioxidants
Chemical Phenomena
Indoles
Spectrometry, Mass, Electrospray Ionization
Monoterpenes
Ligands
Plant Leaves
Models, Chemical
Benzhydryl Compounds
Chromatography, Gas
Cells, Cultured
Coumarins
Amines
Substrate Specificity
Carboxylic Acids
Drugs, Chinese Herbal
Fungi
Biological Assay
Antiviral Agents
Boron Compounds
Spectrometry, Mass, Fast Atom Bombardment
Hydroxybenzoates
Oils, Volatile
Debaromyces
Sulfonium Compounds
Triethylcholine compared with other substances affecting neuromuscular transmission. (1/18)
Triethylcholine (triethyl-2-hydroxyethyl ammonium) has been compared, in its actions on neuromuscular transmission, with the motor end-plate blocking drugs tubocurarine and decamethonium, with the anticholinesterase neostigmine, and with the closely related drug tetraethylammonium. The experiments were carried out on conscious rabbits and mice, on the tibialis anterior muscle of cats under chloralose anaesthesia and on the isolated phrenic nerve-diaphragm preparation of the rat. Anticholinesterase activity was determined manometrically using the Warburg apparatus. Triethylcholine possessed a slight curare-like action, but this effect was shown to be too weak and transient to contribute to the slowly developing and long-lasting transmission failure which occurs selectively in frequently excited nervemuscle preparations and in exercised conscious animals. It was confirmed that the site of the blocking action of triethylcholine was pre-junctional. Triethylcholine often produced a slight potentiation of the contractions before blocking them. This effect was not due to a depolarizing or an anticholinesterase action, and it was concluded that the slight initial facilitating action of triethylcholine on neuromuscular transmission was due to an increase in the quantity of acetylcholine released by the nerve impulse. Tetraethylammonium was much more powerful than triethylcholine in this respect. The pre-junctional transmission failure produced by triethylcholine could not be explained simply on the basis that an initial excessive release led to exhaustion of transmitter. (+info)Effect of beta-diethylaminoethyl 3,3-diphenylpropylacetate on the action of suxamethonium and other neuromuscular blocking drugs. (2/18)
On the frog rectus abdominis muscle and on sciatic nerve-tibialis anterior muscle preparations, beta-diethylaminoethyl 3,3-diphenylpropylacetate (SKF 525A) antagonized the actions of acetylcholine and potassium chloride as well as having an antiveratrine action. The blocking action at the skeletal neuromuscular junction of suxamethonium and its disulphonium analogue, decamethonium, tubocurarine and gallamine was enhanced by SKF 525A in the rabbit and in the isolated rat phrenic nerve-diaphragm preparation. The activity of suxamethonium and decamethonium in the cat was reduced. On the rat phrenic nerve-diaphragm preparation, pretreatment with SKF 525A abolished both the mutual antagonism between suxamethonium and tubocurarine and the antagonizing effect of tetraethylammonium against suxamethonium. Theantagonism between tetraethylammonium and tubocurarine was unimpaired. (+info)Stimulus frequency and neuromuscular block. (3/18)
Muscle twitches of the rat isolated diaphragm and frog sartorius preparations were recorded. It was confirmed that, in the presence of tubocurarine, the degree of neuromuscular block was greater the higher the frequency of stimulation. The results suggest that the quantity of acetylcholine released by each nerve impulse was reduced by increasing the rate of stimulation so that, in a tubocurarine solution, muscle fibres which were only just being fired at a slow rate of stimulation failed to fire at a faster rate. (+info)Interaction of competitive antagonists: the anti-curare action of hexamethonium and other antagonists at the skeletal neuromuscular junction. (4/18)
1. In the rat isolated diaphragm preparation hexamethonium and other low potency competitive antagonists of acetylcholine (ACh), including gallamine and hyoscine butylbromide, reverse block by the potent antagonists tubocurarine, pancuronium and alcuronium. 2. In the presence of tubocurarine, hexamethonium increases the amplitude of the end-plate potential without increasing the quantal content. It enhances the response to ACh applied iontophoretically to the end-plate but does not enhance the response to ACh applied in the bath. 3. The anti-curare effect of hexamethonium is abolished in the diaphragm of the rat, guinea-pig and mouse by inhibitors of acetylcholinesterase. The effect is not observed in the indirectly stimulated toad sartorius muscle. 4. The effect is explained if tubocurarine does not dissociate appreciably in the time taken for ACh to achieve high occupancy of receptors, so that a fraction of receptors is completely excluded from occupation by ACh. Equilibration with hexamethonium reduces the fraction excluded by tubocurarine and the transmitter now competes with hexamethonium for more receptors and produces a larger response. 5. On the basis of this explanation the half-time for dissociation of tubocurarine must be about 1 millisecond. It follows that tubocurarine does not act competitively with ACh at synapses when transmitter action is sufficiently brief, and that its binding to the receptor is probably diffusion-limited. (+info)RNA extraction from various recalcitrant plant tissues with a cethyltrimethylammonium bromide-containing buffer followed by an acid guanidium thiocyanate-phenol-chloroform treatment. (5/18)
High-quality total RNA was extracted using a cethyltrimethylammonium bromide-containing buffer followed by an acid guanidium thiocyanate-phenol-chloroform treatment from recalcitrant plant tissues such as tree leaves (pine, Norway spruce, ginkgo, Japanese cedar, rose), flowers (rose, Lotus japonicus) and storage tissues (seeds of Lotus japonicus and rice, sweet potato tuber, banana fruit). This protocol greatly reduced the time required for RNA extraction. (+info)Discovery of a sensitive, selective, and tightly binding fluorogenic substrate of bovine plasma amine oxidase. (6/18)
(+info)Ionic control of the size of the vesicle matrix of beige mouse mast cells. (7/18)
Isolated matrices of the giant secretory vesicles of mast cells of the beige mouse were reliably produced by the osmotic lysis of isolated vesicles. These matrices maintained their form, and their sizes were easily measured using Nomarski optics. The size of the matrix depended on the ionic composition of the bathing solution. The physiologically relevant ions, histamine and serotonin, contracted the matrix. Multivalent cations condensed the matrix relative to univalents. Ag+, acid pH (below 5), and basic pH (above 9) expanded the matrix. In the presence of 10 mM histamine, lowering the pH from 9 to 5 contracted the matrix more than can be attributed to the pH-dependent matrix contraction in zero histamine. The nontitratable organic cation, dimethonium, contracts the matrix with little effect of pH in the range of 5-9. These results suggest that histamine acts as a matrix contractor in the divalent form. The dose-response (contraction) relation for histamine was gradual from micromolar to 316 mM (millimolar) histamine. Experiments with mixtures of histamine and sodium show antagonistic effects on the matrix but are inconsistent with either a model where ions compete for identical sites or a parallel model where ions interact with separate independent sites. In vigorous histamine washoff experiments, the half time for vesicle expansion in 10(-4) M pH buffer was approximately 4 s; in isotonic NaCl solution, it was 0.5 s. When 1 M histamine was presented to closely apposed matrices, fusion resulted. The matrix material returned to its initial shape after being mechanically deformed with a glass probe. These results suggest that the matrix size is controlled by its ion exchange properties. The matrix expansion can quantitatively account for the vesicular size increase observed upon exocytosis (as a postfusional event) and the osmotic nonideality of intact vesicles. The mechanical expansion is probably significant in the widening of the exocytotic pore and the dispersal of the vesicular contents. (+info)Composition-insensitive highly viscous wormlike micellar solutions formed in anionic and cationic surfactant systems. (8/18)
We investigated phase behavior and rheological properties of aqueous micellar phase formed in water/cocoyl glutamate neutralized with triethanol amine (CGT-n)/hexadecyl trimethylammonium salt (CTAB or CTAC) systems, where n is a degree of neutralization. Micellar phase appears in wide composition range with respect to the surfactant mixing fraction in ternary phase diagrams at 25 degrees C. At high mixing fraction of cationic surfactant in the water/CGT-n/CTAB systems, one can observe a highly viscous micellar phase in which worm-like micelles are expected to form. Contrary to conventional systems in which worm-like micelles are formed, the zero-shear viscosity of the micellar solution in the water/CGT-n/CTAB system with n=1.2 increases with the addition of cationic cosurfactant and once decreases after a maximum, then increases again and decreases after the second maximum. At n=1.5 and 2, highly viscous solution is observed in the relatively wide range of surfactant mixing fraction instead of two maxima of the viscosity curve observed at n=1.2. In the case of CTAC instead of CTAB we can observe narrow composition range for the maximum viscosity. Frequency sweep measurements were performed on the highly viscous samples in the water/CGT-1.5/CTAB system. Typical viscoelastic behavior of worm-like micellar solutions is observed; i.e. the curves of storage (G') and loss (G") moduli make a crossover and the data points of G' and G" can be fitted to the Maxwell model. Relaxation time against the mixing fraction of two surfactants behaves similarly to the zero-shear viscosity change, whereas the plateau modulus continuously increases in the plateau region for the zero-shear viscosity curve. (+info)Gastroenteritis can be classified into different types based on the cause:
Viral gastroenteritis - This is the most common type of gastroenteritis and is caused by norovirus or rotavirus.
Bacterial gastroenteritis - This type is caused by bacteria such as salmonella, E. coli, or campylobacter.
Parasitic gastroenteritis - This is caused by parasites such as giardia or cryptosporidium.
Foodborne gastroenteritis - This type is caused by consuming contaminated food or water.
Gastroenteritis can be treated with antibiotics for bacterial infections, anti-diarrheal medications, and hydration therapy to prevent dehydration. In severe cases, hospitalization may be necessary.
Prevention measures include proper hand washing, avoiding close contact with people who are sick, and avoiding contaminated food and water. Vaccines are also available for some types of gastroenteritis such as rotavirus.
Types of Adenoviridae Infections:
1. Respiratory adenovirus infection (bronchiolitis, pneumonia)
2. Gastroenteric adenovirus infection (gastroenteritis)
3. Eye adenovirus infection (conjunctivitis)
4. Skin adenovirus infection (keratoconjunctivitis)
5. Intestinal adenovirus infection (diarrhea, vomiting)
6. Adenovirus-associated hemorrhagic cystitis
7. Adenovirus-associated hypertrophic cardiomyopathy
8. Adenovirus-associated myocarditis
Symptoms of Adenoviridae Infections:
1. Respiratory symptoms (cough, fever, difficulty breathing)
2. Gastrointestinal symptoms (diarrhea, vomiting, abdominal pain)
3. Eye symptoms (redness, discharge, sensitivity to light)
4. Skin symptoms (rash, blisters, skin erosion)
5. Intestinal symptoms (abdominal cramps, fever, chills)
6. Cardiovascular symptoms (hypertension, tachycardia, myocarditis)
Diagnosis of Adenoviridae Infections:
1. Physical examination and medical history
2. Laboratory tests (rapid antigen detection, PCR, electron microscopy)
3. Imaging studies (chest X-ray, CT scan, MRI)
4. Biopsy (tissue or organ biopsy)
Treatment of Adenoviridae Infections:
1. Supportive care (fluids, oxygen therapy, pain management)
2. Antiviral medications (ribavirin, cidofovir)
3. Immune modulators (immunoglobulins, corticosteroids)
4. Surgical intervention (in severe cases of adenovirus-associated disease)
Prevention of Adenoviridae Infections:
1. Good hygiene practices (handwashing, surface cleaning)
2. Avoiding close contact with individuals who are infected
3. Properly storing and preparing food
4. Avoiding sharing of personal items (utensils, drinking glasses, towels)
5. Immunization (vaccination against adenovirus)
Incubation Period:
The incubation period for adenoviruses is typically between 3-7 days, but it can range from 1-2 weeks in some cases.
Contagious Period:
Adenoviruses are highly contagious and can be transmitted before symptoms appear and during the entire course of illness. The virus can be shed for several weeks after infection.
Risk Factors:
Individuals with weakened immune systems (children, elderly, those with chronic illnesses) are at a higher risk of developing severe adenovirus infections. Additionally, those who live in crowded or unsanitary conditions and those who engage in behaviors that compromise their immune system (smoking, excessive alcohol consumption) are also at a higher risk.
Complications:
Adenovirus infections can lead to a variety of complications, including pneumonia, meningitis, encephalitis, and other respiratory, gastrointestinal, and eye infections. In severe cases, adenovirus infections can be fatal.
Recovery Time:
The recovery time for adenovirus infections varies depending on the severity of the infection and the individual's overall health. Mild cases of adenovirus may resolve within a few days to a week, while more severe cases may take several weeks to recover from. In some cases, hospitalization may be necessary for individuals with severe infections or those who experience complications.
Contraception:
There is no specific contraceptive measure that can prevent adenovirus infections. However, practicing good hygiene, such as frequent handwashing and avoiding close contact with people who are sick, can help reduce the risk of transmission.
Pregnancy:
Adenovirus infections during pregnancy are rare but can be severe. Pregnant women who develop adenovirus infections may experience complications such as preterm labor and low birth weight. It is essential for pregnant women to seek medical attention immediately if they suspect they have an adenovirus infection.
Diagnosis:
Adenovirus infections can be diagnosed through a variety of tests, including polymerase chain reaction (PCR), electron microscopy, and culture. A healthcare provider will typically perform a physical examination and take a medical history to determine the likelihood of an adenovirus infection.
Treatment:
There is no specific treatment for adenovirus infections, but symptoms can be managed with supportive care such as hydration, rest, and over-the-counter pain relievers. Antiviral medications may be prescribed in severe cases or for individuals with compromised immune systems.
Prevention:
Preventing the spread of adenovirus is essential, especially in high-risk populations such as young children and those with weakened immune systems. Practicing good hygiene, such as frequent handwashing and avoiding close contact with people who are sick, can help reduce the risk of transmission. Vaccines are also available for some types of adenovirus.
Prognosis:
The prognosis for adenovirus infections is generally good, especially for mild cases. However, severe cases can lead to complications such as pneumonia, meningitis, and encephalitis, which can be life-threatening. In some cases, long-term health problems may persist after recovery from an adenovirus infection.
Complications:
Adenovirus infections can lead to various complications, including:
1. Pneumonia: Adenovirus can cause pneumonia, which is an inflammation of the lungs that can lead to fever, chest pain, and difficulty breathing.
2. Meningitis: Adenovirus can cause meningitis, which is an inflammation of the membranes surrounding the brain and spinal cord. Symptoms include headache, stiff neck, and sensitivity to light.
3. Encephalitis: Adenovirus can cause encephalitis, which is an inflammation of the brain that can lead to confusion, seizures, and coma.
4. Gastrointestinal symptoms: Adenovirus can cause gastrointestinal symptoms such as diarrhea, vomiting, and abdominal pain.
5. Long-term health problems: In some cases, adenovirus infections can lead to long-term health problems such as asthma, allergies, and autoimmune disorders.
List of MeSH codes (D02)
Carnitine O-acetyltransferase
Onium ion
Molybdate
Pi-interaction
Hydrogen bond
DeCS 2006 - Changed terms
DeCS 2006 - Changed terms
IAEC-13nH Isomeric alcohol ether carboxylate, 86-90
quaternary ammonium ion - Ontology Report - Rat Genome Database
Propano
Tungsten Nanoparticles Nano W Powder CAS 7440-33-7
Local and Travel-Associated Transmission of Tuberculosis at Central Western Border of Brazil, 2014-2017 - Volume 27, Number 3...
Registration Dossier - ECHA
Search Subject Areas | Preprints.org
Amidoamines, Poly Amidoamine | BAOLI Amine Supplier In China
The synthesis steps are simple
Watchdog | Changes July 13, 2020
MeSH Browser
MeSH Browser
NDF-RT Code NDF-RT Name
REPLACED MEDICAL SUBJECT HEADINGS WITH REPLACED-BY HEADINGS - 2006
TERM
Tensoativos
Division of AIDS Anti-HIV/OI/TB Therapeutics Database - Surveillance Memo
Local and Travel-Associated Transmission of Tuberculosis at Central Western Border of Brazil, 2014-2017 - Volume 27, Number 3...
PMID- 19442392
NIDA IRP - Amy Hauck Newman, Ph.D.
Local and Travel-Associated Transmission of Tuberculosis at Central Western Border of Brazil, 2014-2017 - Volume 27, Number 3...
µ
Cationic2
- 16. Cationic vesicles consisting of 1,2-dioleoyl-3-trimethylammonium propane (DOTAP) and phosphatidylcholines and their interaction with erythrocyte membrane. (nih.gov)
- This paper presents a simple treatment of unbleached Norway spruce ( Picea abies ) process water from TMP (thermomechanical pulping) production using induced air flotation (IAF) and cationic surfactant, dodecyl trimethylammonium chloride (DoTAC) to refine the extractives and prepare the waters so that hemicellulose could be easily harvested at a later stage. (ncsu.edu)
Chloride1
- TRUNNANO is a reliable supplier for Dodecyl-bis(2-hydroxyethyl)-methylazanium,chloride. (robocup2009.org)
Cations1
- Compounds containing polymethylene bis-trimethylammonium cations. (nih.gov)
Synthesis2
- 18. Synthesis, structure and biological evaluation of bis salicylaldehyde-4(N)-ethylthiosemicarbazone ruthenium(iii) triphenylphosphine. (nih.gov)
- Fatty acids are an important raw material for the synthesis of organic amine compounds. (blamine.com)
Agents1
- Compounds with this moiety are alkylating agents that may damage DNA. (nih.gov)